Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Auprich Marco |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2013
Originalarbeit (Zeitschrift)
** Hansen, J; Auprich, M; Ahyai, SA; de, la, Taille, A; van, Poppel, H; Marberger, M; Stenzl, A; Mulders, PF; Huland, H; Fisch, M; Abbou, CC; Schalken, JA; Fradet, Y; Marks, LS; Ellis, W; Partin, AW; Pummer, K; Graefen, M; Haese, A; Walz, J; Briganti, A; Shariat, SF; Chun, FK
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
Eur Urol. 2013; 63(2):201-9
Doi: 10.1016/j.eururo.2012.07.030
Web of Science
PubMed
FullText
FullText_MUG
2012
Originalarbeit (Zeitschrift)
** Augustin, H; Auprich, M; Mannweiler, S; Pachernegg, O; Al-Ali, BM; Pummer, K
Prostate cancers detected by saturation repeat biopsy impairs the Partin tables' accuracy to predict final pathological stage.
BJU Int. 2012; 110(3):363-368
Doi: 10.1111/j.1464-410X.2011.10765.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auprich, M; Augustin, H; Budäus, L; Kluth, L; Mannweiler, S; Shariat, SF; Fisch, M; Graefen, M; Pummer, K; Chun, FK
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
BJU Int. 2012; 109(11):1627-1635
Doi: 10.1111/j.1464-410X.2011.10584.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Auprich, M; Chun, FKH; Mayrhofer, K; Haese, A; Mannweiler, S; Ward, JF; Gutschi, ST; Babaian, R; Pummer, K; Augustin, H
Is the preoperative urinary prostate cancer gene 3 (PCA3) score's associated with Gleason score dependent tumor volume and Gleason pattern specific tumor volume?
EUR UROL SUPPL. 2012; 11(1): E1004-U103.
[Poster]
Web of Science
** Auprich, M; Haese, A; De La Taille, A; Van Poppel, H; Marberger, M; Mulders, PFA; Abbou, CC; Stillebroer, AB; Van Gils, PMQ; Schalken, JA; Stenzl, A; Fradet, Y; Marks, LS; Ellis, W; Partin, AW; Walz, J; Chun, FKH
Development of novel PCA3 cut-offs for initial and repeat biopsy using different statistical approaches within a US-European multi institutional cohort
EUR UROL SUPPL. . 2012; 11(1):E263-U696.
[Poster]
Web of Science
** Chun, FK; Hansen, J; De La Taille, A; Van Poppel, H; Marberger, M; Stenzl, A; Mulders, PFA; Huland, H; Abbou, CC; Stillebroer, AB; Van Gils, MPMQ; Schalken, JA; Fradet, Y; Marks, LS; Ellis, W; Partin, AW; Haese, A; Pummer, K; Auprich, M
Biopsy-specific PCA3-based prostate biopsy nomograms are highly accurate
EUR UROL SUPPL. 2012; 11(1):E911-U915.-27th Annual Congress of the European Association of Urology; FEB 24-28, 2012; Paris, FRANCE.
[Oral Communication]
Web of Science
2011
Originalarbeit (Zeitschrift)
** Auprich, M; Chun, FK; Ward, JF; Pummer, K; Babaian, R; Augustin, H; Luger, F; Gutschi, S; Budäus, L; Fisch, M; Huland, H; Graefen, M; Haese, A
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
Eur Urol. 2011; 59(1):96-105
Doi: 10.1016/j.eururo.2010.10.024
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Übersichtsarbeit
** Auprich, M; Bjartell, A; Chun, FK; de la Taille, A; Freedland, SJ; Haese, A; Schalken, J; Stenzl, A; Tombal, B; van der Poel, H
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Eur Urol. 2011; 60(5):1045-1054
Doi: 10.1016/j.eururo.2011.08.003
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Auprich, M; Haese, A; De La Taille, A; Van Poppel, H; Marberger, M; Abbou, CC; Stenzl, A; Mulders, PFA; Schalken, JA; Huland, H; Stillebroer, AB; Van Gils, PMQ; Fradet, Y; Marks, LS; Ellis, W; Partin, AW; Chun, FKH
CRITICAL ASSESSMENT OF URINARY PROSTATE CANCER GENE 3 (PCA3) IN THE PREDICTION OF AGGRESSIVE PROSTATE CANCER (GLEASON SCORE >= 7) AT BIOPSY
EUR UROL SUPPL. 2011; 10(2):207-207.-26th EAU Annual Congress ; MARCH 18-22, 2011; Vienna, AUSTRIA.
Doi: 10.1016/S1569-9056(11)60630-1
[Poster]
Web of Science
FullText
FullText_MUG
** Auprich, M; Haese, A; Ward, JF; Pummer, K; Babaian, R; Augustin, H; Luger, F; Gutschi, S; Budaus, L; Fisch, M; Huland, H; Graefen, M; Chun, FKH
PRE-OPERATIVE URINARY PROSTATE CANCER GENE 3 (PCA3) IN THE PREDICTION OF SMALL TUMOR VOLUME, INSIGNIFICANT, LOCALLY ADVANCED AND AGGRESSIVE PROSTATE CANCER
EUR UROL SUPPL. 2011; 10(2):322-322.-26th Annual EAU Congress in Vienna; MARCH 18-22, 2011; Vienna, AUSTRIA.
Doi: 10.1016/S1569-9056(11)61021-X
[Poster]
Web of Science
FullText
FullText_MUG
2010
Originalarbeit (Zeitschrift)
** Augustin, H; Isbarn, H; Auprich, M; Bonstingl, D; Al-Ali, BM; Mannweiler, S; Pummer, K
Head to head comparison of three generations of Partin tables to predict final pathological stage in clinically localised prostate cancer.
Eur J Cancer. 2010; 46(12): 2235-2241.
Doi: 10.1016/j.ejca.2010.04.013
Web of Science
PubMed
FullText
FullText_MUG
** Auprich, M; Haese, A; Walz, J; Pummer, K; de la Taille, A; Graefen, M; de Reijke, T; Fisch, M; Kil, P; Gontero, P; Irani, J; Chun, FKH
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome.
EUR UROL. 2010; 58(5): 727-732.
Doi: 10.1016/j.eururo.2010.06.038
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Al-Ali, BEM; Auprich, M; Dieber, G; Pummer, K
CHANGE OF QUALITY OF LIFE DUE TO URINARY SYMPTOMS IN GERIATRIC ASA 0 PATIENTS WITH BENIGN PROSTATE HYPERPLASIA(BPH) AND CHRONIC URINARY RETENTION AFTER TRANSURETHRAL MICROWAVE THERMOTHERAPY (TUMT)
EUR UROL SUPPL. 2010; 9(6):625-625.-EAU 10th Central European Meeting; OKT 22 23; Bratislava, SLOWAKEI.
[Poster]
Web of Science
** Al-Ali, BEM; Auprich, M; Pummer, K; Augustin, H; Ponholzer, A; Madersbacher, S
Longterm lower urinary tract function after radical retropubic prostatectomy a comparison to healthy age-matched men
EUR UROL SUPPL. 2010; 9(6):624-625.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN.
[Poster]
Web of Science
** Auprich, M; Budaus, L; Chun, FK; Luger, F; Gutschi, S; Galle, G; Mannweiler, S; Purstner, P; Augustin, H; Pummer, K
Head to head comparison of the urinary PCA3 and PSA velocity as risk factors for prostate cancer prediction in patients undergoing repeat prostate biopsy
EUR UROL SUPPL. 2010; 9(6):631-631.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN.
Doi: 10.1016/S1569-9056(10)61571-0
[Poster]
Web of Science
FullText
FullText_MUG
** Auprich, M; Budäus, L; Luger, F; Pichler, M; Gallé, G; Mannweiler, S; Chun, FK; Pürstner, P; Pummer, K; Augustin, H
PSA velocity and PCA3 score as risk factors for prostate cancer in a repeat biopsy setting improves the predictive accuracy in a multivariate model.
European Urology Supplements2010; 9(2):307--25th Anniversary European Association of Urology Congress; APR 16-20, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
** Auprich, M; Gutschi, S; Luger, F; Galle, G; Mannweiler, S; Purstner, P; Augustin, H; Pummer, K
Influence of transurethral resection of the prostate (TUR-P) on prostate cancer gene 3 (PCA3): Results from a six months prospective trial
EUR UROL SUPPL. 2010; 9(6):625-625.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN.
Doi: 10.1016/S1569-9056(10)61548-5
[Poster]
Web of Science
FullText
FullText_MUG
** Auprich, M; Gutschi St; Galle, G; Pichler, M; Mannweiler, S; Pummer, K; Augustin, H
Systematic analysis of saturation biopsy with 20 peripheral cores and 4 cores from the transition zone based on 62 reduced biopsy schemes after at least one negative biopsy
EUR UROL SUPPL. 2010; 9(6):654-654.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN.
Doi: 10.1016/S1569-9056(10)61668-5
[Poster]
Web of Science
FullText
FullText_MUG
** Auprich, M; Haese, A; Graefen, M; Stenzl, A; Marberger, M; De La Taille, A; De Reijke, T; Kil, P; Gontero, P; Van Poppel, H; Irani, J; Chun, FK
External validation of PCA3- based nomograms for predicting positive biopsy for prostate cancer.
European Urology Supplements2010; 9(2):307--25th Anniversary European Association of Urology Congress; APR 16-20, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
** Budäus, L; Spethmann, J; Salomon, G; Isbarn, H; Auprich, M; Steuber, T; Haese,A; Schlomm, T; Heinzer, H; Huland, H; Karakiewicz, PI; Graefen, M
Elderly patients are at a more elevated risk of pt 3 prostate cancer: Results of a European single center.
European Urology Supplements2010; 9(2):223--25th Anniversary European Association of Urology Congress; APR 16-20, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
2009
Originalarbeit (Zeitschrift)
** Augustin, H; Fritz, GA; Ehammer, T; Auprich, M; Pummer, K
Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables.
Acta Radiol. 2009; 50(5): 562-569.
Doi: 10.1080/02841850902889846
Web of Science
PubMed
FullText
FullText_MUG
** Mannweiler, S; Pummer, K; Auprich, M; Galle, G; Méhes, G; Ratschek, M; Tsybrovskyy, O; Moinfar, F
Diagnostic yield of touch imprint cytology of prostate core needle biopsies.
Pathol Oncol Res. 2009; 15(1):97-101
Doi: 10.1007/s12253-008-9114-0
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Augustin, H; Auprich, M; Bonstingl, D; Mannweiler, S; Gutschi, S; Gallé, G; Mohamad Al-Ali, B; Pummer, K
Two generations of Partin Tables: Comparison of predictive accuracy
European Urology Supplements 2009; 8(8):690-690.-EAU 9th Central European Meeting; OCT 23-24, 2009; Ljubljana,SLOVENIA.
[Poster]
Web of Science
** Augustin, H; Auprich, M; Gallé, G; Gutschi, S; Peteani, R; Mannweiler, S; Mohamad-Al-Ali, B; Pummer, K
Comparison of clinical and pathological features between prostate cancers detected by the first biopsy and by re-biopsy with an extended scheme
European Urology Supplements 2009; 8(8):690-690.-EAU 9th Central European Meeting; OCT 23-24, 2009; Ljubljana, SLOVENIA.
[Poster]
Web of Science
** Auprich, M; Mannweiler, S; Galle, G; Tsybrovskyy, O; Ratschek, M; Moinfar, F; Pummer, K
TOUCH IMPRINT CYTOLOGY OF PROSTATE CORE NEEDLE BIOPSIES IMPROVES DETECTION RATE FOR PROSTATE CANCER
EUR UROL SUPPL. 2009; 8(4):218-218.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN.
Doi: 10.1016/S1569-9056(09)60392-4
[Poster]
Web of Science
FullText
FullText_MUG
** Mohamad Al-Ali, B; Pummer, K; Auprich, M
Biological effects of SWL( shock wave lithotripsy)
European Urology Supplements. 2009; 8(8):686-686.-EAU 9th Central European Meeting; 23-24 -10-2009; Ljubljana.
[Poster]
Web of Science
2008
Originalarbeit (Zeitschrift)
** Vener, T; Derecho, C; Baden, J; Wang, H; Rajpurohit, Y; Skelton, J; Mehrotra, J; Varde, S; Chowdary, D; Stallings, W; Leibovich, B; Robin, H; Pelzer, A; Schäfer, G; Auprich, M; Mannweiler, S; Amersdorfer, P; Mazumder, A
Development of a multiplexed urine assay for prostate cancer diagnosis.
Clin Chem. 2008; 54(5): 874-882.
Doi: 10.1373/clinchem.2007.094912
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Abstract (Zeitschrift)
** Galle, G; Augustin, H; Auprich, M; Gutschi, S; Pummer, K; Petritsch, P
Repeat prostate biopsy: Comparison of cancer detection between the 24 core saturation biopsy scheme and 2 different 12 core schemes.
EUR UROL SUPPL. 2007; 6(2):121-121.-22nd Annual Congress of the European Association of Urology; MAR 21-24, 2007; Berlin, GERMANY.
Doi: 10.1016/S1569-9056(07)60394-7
[Poster]
Web of Science
FullText
FullText_MUG
2006
Originalarbeit (Zeitschrift)
** Augustin, H; Auprich, M; Stummvoll, P; Lipsky, K; Pummer, K; Petritsch, P
Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era.
Wien Klin Wochenschr. 2006; 118(11-12):348-354
Doi: 10.1007/s00508-006-0608-z
Web of Science
PubMed
FullText
FullText_MUG
** Brössner, C; Petritsch, K; Fink, K; Auprich, M; Ponholzer, A; Madersbacher, S; Adlercreutz, H; Petritsch, P
Prostatic phyto-oestrogen tissue levels in different Austrian regions.
UROL INT. 2006; 76: 327-331.
Doi: 10.1159/000092056
Web of Science
PubMed
FullText
FullText_MUG
2005
Abstract (Zeitschrift)
** Zigeuner, RE; Langner, C; Rehak, P; Auprich, M; Lipsky, K; Pummer, K; Schips, L
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
J UROL 2005 173: 98-98.
Doi: 10.1016/S0022-5347(18)34612-3
Web of Science
FullText
FullText_MUG
2004
Originalarbeit (Zeitschrift)
** Brössner, C; Petritsch, K; Fink, K; Auprich, M; Madersbacher, S; Adlercreutz, H; Rehak, P; Petritsch, P
Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Urology. 2004; 64(4):707-711
Doi: 10.1016/j.urology.2004.04.046
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2003
Originalarbeit (Zeitschrift)
** Zigeuner, R; Schips, L; Lipsky, K; Auprich, M; Salfellner, M; Rehak, P; Pummer, K; Hubmer, G
Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies.
Urology. 2003; 62(5):883-887
Doi: 10.1016/S0090-4295(03)00663-0
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zigeuner, RE; Lipsky, K; Riedler, I; Auprich, M; Schips, L; Salfellner, M; Pummer, K; Hubmer, G
Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients.
Urology. 2003; 62(3):451-455
Doi: 10.1016%2FS0090-4295%2803%2900459-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2001
Kommentar
** Zitta, S; Auprich, M; Holzer, H; Reibnegger, G
Cystatin C concentration and glomerular filtration rate.
Lancet. 2001; 357(9256):635-635
Doi: 10.1016/S0140-6736(05)71424-0
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar